Drug profile

The FDA adverse-event record for Suture

11 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Suture. See the species affected, top reactions, and outcomes below.

11
adverse-event reports
27.3%
death-coded share
Dog
most-reported species
3
Lethargy (see also Central nervous system depression in 'Neurological') - top reaction
Verify with FDA CVM →
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
11
Total Reports
3
Deaths Reported
27.3%
Death Rate

Active Ingredients

Suture

Administration Routes

UnknownSubcutaneousOtherIntramuscularIntradermal

Species Affected

Dog 7
Cat 3
Cattle 1

Most Affected Breeds

Domestic Shorthair 3
Pit Bull 3
Terrier - Yorkshire 1
Retriever - Labrador 1
Boxer (German Boxer) 1
Shepherd Dog - Australian 1
Aberdeen Angus 1

Most Reported Reactions

Lethargy (see also Central nervous system depression in 'Neurological') 3
Other abnormal test result NOS 3
Vomiting 3
Weight loss 2
Skin necrosis 2
Dehydration 2
Seroma 2
Death by euthanasia 2
Implant site reaction NOS 2
Hyperphosphataemia 2
Abnormal ultrasound finding 2
Lymphopenia 2

Outcome Breakdown

Ongoing
3 (27.3%)
Recovered/Normal
3 (27.3%)
Euthanized
2 (18.2%)
Outcome Unknown
2 (18.2%)
Died
1 (9.1%)

Suture Adverse Event Insights

11 reports name Suture; 3 recorded a death outcome (27.3% of reported events, not a population-level mortality rate). Active ingredient: Suture. Administration routes: Unknown, Subcutaneous, Other, Intramuscular.

By species: Dog (7 reports), Cat (3 reports), Cattle (1 reports). By breed: Domestic Shorthair (3), Pit Bull (3), Terrier - Yorkshire (1).

Leading clinical signs: Lethargy (see also Central nervous system depression in 'Neurological') (3), Other abnormal test result NOS (3), Vomiting (3), Weight loss (2). Outcome, 11 coded reports: Ongoing leads at 27.3%.

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. This page draws directly on FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.